Product Details

Auro-Ciprofloxacin

Ciprofloxacin
500 mg
Tablet


DIN/PIN/NPN

02381923

Manufacturer

Auro Pharma Inc.

Formulary Listing Date

2012-08-27  

Unit Price

0.5025

Amount MOH Pays

0.5025

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Ciprofloxacin: Ciprofloxacin is not intended for the treatment of asymptomatic bacteriuria in the absence of risk factors. Avoid use in pregnancy and children <18 years of age. Ciprofloxacin inhibits theophylline clearance and also affects phenytoin kinetics. Theophylline doses should be decreased and blood levels of phenytoin or theophylline monitored when either of these drugs is used concomitantly with ciprofloxacin.

ATC Code

J01MA02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02379635 Septa-Ciprofloxacin 0.5025 0.5025
02248757 Sandoz Ciprofloxacin 0.5025 0.5025
02246826 Ratio-Ciprofloxacin 0.5025 0.5025
02303736 Ran-Ciproflox 0.5025 0.5025
02248438 PMS-Ciprofloxacin 0.5025 0.5025
02492008 NRA-Ciprofloxacin 0.5025 0.5025
02423561 Mint-Ciproflox 0.5025 0.5025
02379694 Mar-Ciprofloxacin 0.5025 0.5025
02380366 Jamp-Ciprofloxacin 0.5025 0.5025
02247340 Co Ciprofloxacin 0.5025 0.5025
02386127 Ciprofloxacin 0.5025 0.5025
02353326 Ciprofloxacin 0.5025 0.5025
02155966 Cipro NA NA
02381923 Auro-Ciprofloxacin 0.5025 0.5025
02229522 Apo-Ciproflox 0.5025 0.5025
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph